Electrochemical Biosensor for Autoantibody Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional testing for autoantibodies is labor-intensive, expensive, and centralized, making it cumbersome and time-consuming, which limits its diagnostic value and accessibility, especially in primary care settings where a point-of-care diagnostic tool is needed for autoimmune disease detection.
Innovation Solution
A portable electrochemical biosensor device with multiple reaction zones and a porous membrane for immobilizing autoantigens, allowing for rapid analysis of biological samples using an anti-human IgG enzyme conjugate to detect autoantibodies, providing a point-of-care diagnostic test that can be completed within 30 minutes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional testing methods are used for autoantibody detection, then measurement precision is maintained, but productivity is reduced and loss of time increases
Solution Approach 1:
The patent replaces conventional mechanical/chemical ELISA methods with an electrochemical detection system. The electrochemical biosensor uses electrical signals to detect autoantibodies, eliminating the need for manual washing steps, colorimetric reactions, and plate reading equipment. This substitution maintains measurement precision while dramatically improving productivity by enabling rapid sequential testing.
Solution Approach 2:
The invention changes the detection parameter from optical (colorimetric) to electrochemical. By measuring electrical current or potential changes instead of color intensity, the system achieves both high precision comparable to conventional methods and significantly faster throughput. The electrochemical signal can be rapidly measured without the time-consuming steps required by optical methods.
2Measurement precision
If conventional centralized testing is used, then measurement precision is maintained, but device complexity and ease of operation worsen due to laboratory requirements
Solution Approach 1:
The patent extracts the detection function from the complex centralized laboratory environment and consolidates it into a single integrated portable device. The electrochemical biosensor combines sample processing, antigen exposure, and detection into one unit that can be operated without laboratory infrastructure. This extraction maintains precision by preserving the core immunological reaction while eliminating the need for complex laboratory equipment and procedures.
Solution Approach 2:
The portable electrochemical device performs multiple functions in a single unit: it houses the antigen array, provides fluid handling capabilities, integrates the electrochemical sensor, and includes data processing. This multi-functionality consolidates what would traditionally require multiple separate laboratory instruments and procedures into one device that can be operated in diverse settings while maintaining diagnostic precision.
3Measurement precision
If conventional testing procedures are used, then measurement precision is maintained, but loss of time increases due to multiple processing steps
Solution Approach 1:
The electrochemical biosensor enables continuous processing where sample application, antigen binding, and detection occur in an integrated flow. Unlike conventional methods that require sequential discrete steps with waiting periods, the electrochemical system maintains continuous useful action by immediately detecting bound antibodies through electrical signals as they form, eliminating idle time between processing stages while maintaining quantification accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The device enables accurate and rapid detection of autoantibodies, offering a cost-effective, reliable, and portable solution for identifying autoimmune diseases at the point of care, reducing the need for centralized laboratories and improving diagnostic efficiency.
Implementation Method 1
A first reaction zone includes a porous membrane and a first electrode assembly in fluid communication with a first channel. The first reaction zone also includes a first plurality of autoantigens immobilized to the porous membrane.
Implementation Method 2
drawing at least a portion of an anti-human IgG preparation through the first reaction zone in fluid communication with the first channel, the anti-human IgG comprising an enzyme that catalyzes an electrode-detectable reaction in the presence of a suitable substrate
Implementation Method 3
contacting the suitable substrate with the first reaction zone under conditions suitable for the enzyme to catalyze the electrode-detectable reaction, and measuring the electrode-detectable reaction
Implementation Method 4
the device includes a source of negative pressure in fluid communication with the first reaction zone and the second reaction zone
Data Source
AI summary
This disclosure describes, in one aspect, a device for electrochemical quantitation of autoantibodies. Generally, the device includes a housing that defines a plurality of channels and at least two reaction zones. A first reaction zone includes a porous membrane and a first electrode assembly in fluid communication with a first channel. The first reaction zone also includes a first plurality of autoantigens immobilized to the porous membrane. The first electrode assembly is in communication with an amperometric reader. A second reaction zone includes a porous membrane and a second electrode assembly in fluid communication with a second channel. The second reaction zone includes a second plurality of autoantigens immobilized to the porous membrane. The second electrode assembly is in communication with the amperometric reader. Finally, the device includes a source of negative pressure in fluid communication with the first reaction zone and the second reaction zone.